We have already received merger clearance in every jurisdiction other than China based on the merits of our transaction and the significant benefits it is expected to bring to all our stakeholders and the future of
technology innovation. We continue to work collaboratively with the State Administration for Market Regulation of China, and we are at an advanced stage in obtaining this final regulatory approval.
Synopsys, Inc.
650-584-5000
Mary Kate Joyce
ANSYS, Inc.
724-820-4368
Cautionary Statement Regarding Forward-Looking Statements
This communication may contain certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Synopsys and Ansys, including, but not limited to, statements regarding the
anticipated timing of the closing thereof and the regulatory approvals required for completion of the proposed transaction. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,”
“estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions or the negatives of these words or other comparable terminology to
convey uncertainty of future events or outcomes.
Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties and other factors that could cause
actual future events to differ materially from the forward-looking statements in this communication, including, but not limited to: (i) the completion of the proposed transaction on anticipated terms and timing, (ii) the failure to satisfy the
conditions to the consummation of the proposed transaction, including the receipt of certain governmental and regulatory approvals on the terms expected, in a timely manner, or at all, (iii) the risk that such regulatory approvals may result in
the imposition of conditions that could adversely affect, following completion of the proposed transaction (if completed), the combined company or the expected benefits of the proposed transaction, (iv) the occurrence of any event, change or
other circumstance that could give rise to the termination of the merger agreement, (v) the effect of the pendency of the proposed transaction on Ansys’ or Synopsys’ business relationships, competition, business, financial condition, and
operating results, (vi) risks that the proposed transaction disrupts current plans and operations of Ansys or Synopsys and the ability of Ansys or Synopsys to retain and hire key personnel, (vii) risks related to diverting either management
team’s attention from ongoing business operations of Ansys or Synopsys, (viii) the outcome of any legal proceedings that may be instituted against Ansys or Synopsys related to the merger agreement or the proposed transaction, (ix) the ability of
Synopsys to successfully integrate Ansys’ operations and product lines, (x) the ability of Synopsys to implement its plans, forecasts, expected financial performance and other expectations with respect to Ansys’ business or the combined business
after the completion of the proposed transaction and realize the benefits expected from the proposed transaction (if completed), as well as manage the scope and size of the combined company, (xi) risks associated with third party contracts
containing consent and/or other provisions that may be triggered by the proposed transaction, (xii) uncertainty in the macroeconomic and geopolitical environment and its potential impact on the semiconductor and electronics industries, (xiii)
uncertainty in the growth of the semiconductor, electronics and artificial intelligence industries, (xiv) the highly competitive industries in which Synopsys and Ansys operate, (xv) actions by the U.S. or foreign governments, such as the
assessment of fines or the imposition of additional export restrictions or tariffs, (xvi) the evolving legal, regulatory and tax regimes under which Ansys and Synopsys operate, and (xvii) restrictions during the pendency of the proposed
transaction that may impact Ansys’ or Synopsys’ ability to pursue certain business opportunities or strategic transactions.
These risks, uncertainties and factors, as well as other risks associated with the proposed transaction, are more fully discussed in the proxy statement/prospectus filed with the SEC in connection with the proposed transaction. While the list
of risks, uncertainties and factors presented here, and the list of risks presented in the proxy statement/prospectus, are considered representative, no such list is exhaustive. Unlisted risks, uncertainties and factors may present significant
additional obstacles to the realization of forward-looking statements.
You should carefully consider the foregoing factors and the other risks and uncertainties that affect the businesses of Synopsys and Ansys described in the “Risk Factors” section of their respective Annual Reports on Form 10-K, Quarterly
Reports on Form 10-Q and other documents filed by either of them from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those
contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond
Synopsys’ and Ansys’ control, and are not guarantees of future results. Readers are cautioned not to put undue reliance on forward-looking statements, and Synopsys and Ansys assume no obligation and do not intend to update or revise these
forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law. Neither Synopsys nor Ansys gives any assurance that either Synopsys or Ansys will achieve its expectations.